Page 40 - Peptide News Today

(0) - Since the geriatric population is more susceptible to various chronic conditions, the global peptide therapeutics market is expected to expand at a rapid pace. - Technological advances have helped to reduce the overall costs associated with the making of therapeutic peptides, encouraging producers and manufacturers to look for new ways to produce therapeutic peptides. ALBANY, N.Y., April 13, 2021 /PRNewswire/ -- The global peptide therapeutics market is expected to expand due to the high ...

VBI Vaccines Announces Phase 1b/2a Data and Progress of Hepatitis B Immunotherapeutic Candidate

(2) ZURICH-SCHLIEREN, SWITZERLAND / ACCESSWIRE / March 10, 2021. Molecular Partners AG (SIX:MOLN), a clinical-stage biotech company that is developing a new class of custom-built protein drugs known as DARPin® therapeutics, today announced the upcoming presentation of four posters with data supporting three of the companys immunotherapy programs at the American Academy for Cancer Research (AACR) Virtual Annual Meeting running April 10-15, 2021. The accepted research describes multiple aspects...

(1) LONDON, Feb. 23, 2021 (GLOBE NEWSWIRE) -- OKYO Pharma Limited ("OKYO" or the "Company"), a biotechnology company focused on the development of novel drugs to treat inflammatory eye diseases and chronic ocular pain, today announced that patent No. 10,899,796 entitled "Compounds and Methods for Treating Pain" was issued by the United States Patent and Trademark Office ("USPTO") on January 26, 2021. This patent covers a class of bovine adrenal medulla (BAM) peptides linked to specific lipids...

Researchers at Cornell, Columbia University Irving Medical Center and Erasmus Medical Center in the Netherlands have developed a nasal formulation that blocks the spread of COVID-19 among ferrets – and are hopeful the formulation could have the same effect on humans, and potentially generate therapeutic treatments as well. Ferrets are one of the best animal models for COVID-19, because they take the virus quite readily, and undergo both direct contact and airborne transmission. Ferrets, si...

Hits: 1213 BENGALURU, India I February 12, 2021 I “This is to inform that Biocon Biologics Ltd., a subsidiary of Biocon Ltd. (BSE code: 532523, NSE: BIOCON), has announced that Kixelle, a biosimilar Insulin Aspart co-developed with Viatris Inc. (NASDAQ: VTRS), has received marketing authorization approval from the European Commission following the positive recommendation by the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency. Kixelle, a fast-acting ...

Support for Blueberry Import Case and Aussie Plant Fights Citrus Greening Thursday Feb 11th, 2021 **EARTHDAY.ORG is formally launching its Regenerative Agriculture program. The campaign works to educate and raise awareness of regenerative agriculture and its positive impact on the environment, public health and food justice. Regenerative agriculture counters climate change and promotes food security by restoring soil, organic matter, and biodiversity as well as reducing atmospheric carbon. Lea...

Researchers find peptide that treats, prevents citrus disease ANI | Updated: Feb 08, 2021 18:59 IST Washington [US], February 8 (ANI): New research affirms a unique peptide found in an Australian plant can destroy the No. 1 killer of citrus trees worldwide and help prevent infection. Huanglongbing, HLB, or citrus greening has multiple names, but one ultimate result: bitter and worthless citrus fruits. It has wiped out citrus orchards across the globe, causi...

Hits: 1900 - Seed investment by Swanbridge Capital and Van Herk Ventures with support from Health~Holland ROTTERDAM, The Netherlands I February 8, 2021 I Pan Cancer T B.V., a biotech spin-off from the Erasmus Medical Center founded by Prof. Dr. Reno Debets (CSO) and Dr. Dora Hammerl (VP R&D), announces the closing of a seed investment and start of operations. Together with Katrien Reynders-Frederix (CEO), the team is committed to the discovery and development of novel TCR therapies against ...

Phototherapy Technology may Treat Cancer Completely by Karishma Abhishek on  January 15, 2021 at 6:20 PM Theragnosis Research Center (KU-KIST Graduate School of Converging Science and Technology). The phototherapy technology involves only one injection and repeated phototherapy. It is a cancer treatment technique where light is used and a photosensitizer is injected, that selectively destroys cancer cells in response to a laser, which accumulates in only cancerous tis...